{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T11:26:17Z","timestamp":1791285977615,"version":"4.1.0"},"reference-count":189,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":2023,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1016\/j.jhep.2008.01.020","type":"journal-article","created":{"date-parts":[[2008,2,12]],"date-time":"2008-02-12T15:10:23Z","timestamp":1202829023000},"page":"S38-S57","source":"Crossref","is-referenced-by-count":125,"special_numbering":"S1","title":["The challenges in primary sclerosing cholangitis \u2013 Aetiopathogenesis, autoimmunity, management and malignancy"],"prefix":"10.1016","volume":"48","author":[{"given":"Tobias J.","family":"Weism\u00fcller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Wedemeyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kubicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian P.","family":"Strassburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Manns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2008.01.020_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.7326\/0003-4819-3-4-335","article-title":"Complications and sequelae of chronic ulcerative colitis","volume":"3","author":"Bargen","year":"1929","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib2","first-page":"259","article-title":"Liver damage in ulcerative colitis","volume":"28","author":"Kimmelstiel","year":"1952","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2008.01.020_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/bega.2001.0204","article-title":"Epidemiology of primary sclerosing cholangitis","volume":"15","author":"Schrumpf","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/00365529850166284","article-title":"Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population","volume":"33","author":"Boberg","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1111\/j.1572-0241.2007.01103.x","article-title":"The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis","volume":"102","author":"Kaplan","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib6","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib7","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1053\/j.gastro.2004.04.052","article-title":"Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom","volume":"126","author":"Kingham","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib8","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0168-8278(94)80240-8","article-title":"Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver","volume":"21","author":"Escorsell","year":"1994","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib9","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1046\/j.1440-1746.2002.02835.x","article-title":"Clinical profile of primary sclerosing cholangitis in Singapore","volume":"17","author":"Ang","year":"2002","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.hepres.2004.03.006","article-title":"Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients","volume":"29","author":"Takikawa","year":"2004","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2008.01.020_bib11","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/j.1572-0241.2002.06019.x","article-title":"Prevalence of autoimmune liver disease in Alaska Natives","volume":"97","author":"Hurlburt","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/gut.51.4.567","article-title":"Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study","volume":"51","author":"Mitchell","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1053\/gast.1996.v110.pm8613055","article-title":"Primary sclerosing cholangitis is associated with nonsmoking: a case-control study","volume":"110","author":"Loftus","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib15","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0168-8278(01)00288-4","article-title":"Hepatic and extrahepatic malignancies in primary sclerosing cholangitis","volume":"36","author":"Bergquist","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broome","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib18","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1055\/s-2006-933559","article-title":"Etiopathogenesis of primary sclerosing cholangitis","volume":"26","author":"O\u2019Mahony","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2008.01.020_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1385\/CRIAI:28:2:093","article-title":"Immunopathogenesis of primary sclerosing cholangitis","volume":"28","author":"Worthington","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2008.01.020_bib20","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1111\/j.1572-0241.2000.03292.x","article-title":"Increased frequency of autoimmune diseases in patients with primary sclerosing cholangitis","volume":"95","author":"Saarinen","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib21","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jhep.2004.10.011","article-title":"Increased prevalence of primary sclerosing cholangitis among first-degree relatives","volume":"42","author":"Bergquist","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib22","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/gut.2003.031732","article-title":"Genetics of liver disease: immunogenetics and disease pathogenesis","volume":"53","author":"Donaldson","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib23","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1053\/gast.2001.24041","article-title":"Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism","volume":"120","author":"Norris","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib24","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1080\/0891693021000054093","article-title":"Evaluation of the role of MHC class II alleles, haplotypes and selected amino acid sequences in primary sclerosing cholangitis","volume":"35","author":"Donaldson","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jhep.2008.01.020_bib25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1034\/j.1399-0039.1999.530502.x","article-title":"HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations","volume":"53","author":"Spurkland","year":"1999","journal-title":"Tissue Antigens"},{"key":"10.1016\/j.jhep.2008.01.020_bib26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/01.MIB.0000209790.21737.28","article-title":"CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis","volume":"12","author":"Henckaerts","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2008.01.020_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/sj.gene.6364113","article-title":"CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis","volume":"5","author":"Eri","year":"2004","journal-title":"Genes Immun"},{"key":"10.1016\/j.jhep.2008.01.020_bib28","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jhep.2003.11.009","article-title":"Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1","volume":"40","author":"Yang","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib29","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jhep.2006.03.012","article-title":"Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis","volume":"45","author":"Bowlus","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/gut.49.2.288","article-title":"Association of the tumour necrosis factor alpha-308 but not the interleukin 10-627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis","volume":"49","author":"Mitchell","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib31","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/j.1572-0241.2005.41072.x","article-title":"Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis","volume":"100","author":"Gallegos-Orozco","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib32","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s00439-003-0963-z","article-title":"Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis","volume":"113","author":"Sheth","year":"2003","journal-title":"Hum Genet"},{"key":"10.1016\/j.jhep.2008.01.020_bib33","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0168-8278(00)80061-6","article-title":"Serum autoantibodies in patients with primary sclerosing cholangitis","volume":"32","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib34","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840170310","article-title":"Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases","volume":"17","author":"Mulder","year":"1993","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib35","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/gut.38.3.384","article-title":"Importance of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and ulcerative colitis: prevalence, titre, and IgG subclass","volume":"38","author":"Bansi","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1385\/CRIAI:28:2:115","article-title":"Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases","volume":"28","author":"Terjung","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2008.01.020_bib37","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1053\/gast.2000.9366","article-title":"\u201cAtypical p-ANCA\u201d in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines","volume":"119","author":"Terjung","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840030203","article-title":"Elevated circulating immune complexes in primary sclerosing cholangitis","volume":"3","author":"Bodenheimer","year":"1983","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib39","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/0016-5085(89)90386-7","article-title":"Activation of the complement system in primary sclerosing cholangitis","volume":"97","author":"Senaldi","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib40","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib41","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2008.01.020_bib42","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7861\/clinmedicine.4-2-173","article-title":"Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease","volume":"4","author":"Eksteen","year":"2004","journal-title":"Clin Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib43","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00054725-199805000-00026","article-title":"Endothelial ligands and homing of mucosal leukocytes in extraintestinal manifestations of IBD","volume":"4","author":"Salmi","year":"1998","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2008.01.020_bib44","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1053\/jhep.2001.24231","article-title":"MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease)","volume":"33","author":"Grant","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib45","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib46","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/gut.21.10.851","article-title":"Bacteriological and endotoxin studies in cases of ulcerative colitis submitted to surgery","volume":"21","author":"Palmer","year":"1980","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib47","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hep.1840010612","article-title":"Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis","volume":"1","author":"Ludwig","year":"1981","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib48","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0016-5085(90)90833-M","article-title":"Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth","volume":"98","author":"Lichtman","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib49","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1080\/00365520510023288","article-title":"Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis","volume":"40","author":"Bjornsson","year":"2005","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib50","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1128\/JCM.38.3.1072-1076.2000","article-title":"Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis","volume":"38","author":"Nilsson","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jhep.2008.01.020_bib51","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.femsim.2004.11.002","article-title":"The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis","volume":"44","author":"Boomkens","year":"2005","journal-title":"FEMS Immunol Med Microbiol"},{"key":"10.1016\/j.jhep.2008.01.020_bib52","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1007\/s10620-007-9803-7","article-title":"Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis","volume":"52","author":"Krasinskas","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2008.01.020_bib53","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0168-8278(92)90076-2","article-title":"A survey of cytomegalovirus (CMV) DNA in primary sclerosing cholangitis (PSC) liver tissues using a sensitive polymerase chain reaction (PCR) based assay","volume":"15","author":"Mehal","year":"1992","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib54","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0168-8278(87)80054-5","article-title":"Reovirus type 3 infection in patients with primary biliary cirrhosis and primary sclerosing cholangitis","volume":"5","author":"Minuk","year":"1987","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib55","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00042737-200601000-00012","article-title":"The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis","volume":"18","author":"Pohl","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib56","first-page":"1504","article-title":"Bile duct bacterial isolates in primary sclerosing cholangitis and certain other forms of cholestasis \u2013 a study of bile cultures from ERCP","volume":"47","author":"Bjornsson","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib57","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.jhep.2006.07.022","article-title":"Biliary Candida infections in primary sclerosing cholangitis","volume":"45","author":"Kulaksiz","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib58","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/01.mog.0000218965.78558.bc","article-title":"Cholangiocyte biology","volume":"22","author":"Tietz","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib59","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1053\/j.gastro.2004.08.006","article-title":"The cholangiopathies: disorders of biliary epithelia","volume":"127","author":"Lazaridis","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib60","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1056\/NEJM199810223391707","article-title":"Molecular pathogenesis of cholestasis","volume":"339","author":"Trauner","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib61","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/j.gastro.2005.10.018","article-title":"24-norUrsodeoxycholic acid is superior to ursodeoxycholic acid in the treatment of sclerosing cholangitis in Mdr2 (Abcb4) knockout mice","volume":"130","author":"Fickert","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib62","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1053\/gast.2002.35948","article-title":"Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles","volume":"123","author":"Fickert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib63","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/hep.20159","article-title":"BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis","volume":"39","author":"Pauli-Magnus","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib64","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/0016-5085(90)90839-S","article-title":"A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody","volume":"98","author":"Das","year":"1990","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0016-5085(94)95271-X","article-title":"Autoantibodies in sclerosing cholangitis against a shared peptide in biliary and colon epithelium","volume":"106","author":"Mandal","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib66","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gut.51.1.120","article-title":"High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6","volume":"51","author":"Xu","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib67","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1053\/j.gastro.2007.01.039","article-title":"Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis","volume":"132","author":"Karrar","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib68","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1053\/gast.2001.25516","article-title":"Proinflammatory cytokines inhibit secretion in rat bile duct epithelium","volume":"121","author":"Spirli","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib69","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/gast.2003.50100","article-title":"Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes","volume":"124","author":"Spirli","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib70","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1007\/s10620-006-9681-4","article-title":"Incidence, diagnosis, and therapy of cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"52","author":"Fevery","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2008.01.020_bib71","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.freeradbiomed.2005.07.005","article-title":"Glycochenodeoxycholate plays a carcinogenic role in immortalized mouse cholangiocytes via oxidative DNA damage","volume":"39","author":"Komichi","year":"2005","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib72","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jhep.2005.10.030","article-title":"Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes","volume":"44","author":"Meng","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib73","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s005340070039","article-title":"p53 overexpression and K-ras gene mutations in primary sclerosing cholangitis-associated biliary tract cancer","volume":"7","author":"Ahrendt","year":"2000","journal-title":"J Hepatobiliary Pancreat Surg"},{"key":"10.1016\/j.jhep.2008.01.020_bib74","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/S0168-8278(00)80386-4","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: K-ras mutations and Tp53 dysfunction are implicated in the neoplastic development","volume":"32","author":"Boberg","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib75","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1053\/gast.2002.36021","article-title":"p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma","volume":"123","author":"Taniai","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib76","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1006\/jsre.1999.5615","article-title":"Chromosome 9p21 loss and p16 inactivation in primary sclerosing cholangitis-associated cholangiocarcinoma","volume":"84","author":"Ahrendt","year":"1999","journal-title":"J Surg Res"},{"key":"10.1016\/j.jhep.2008.01.020_bib77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/hep.1840100406","article-title":"Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis","volume":"10","author":"Wiesner","year":"1989","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib78","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365520600787994","article-title":"Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden","volume":"42","author":"Bergquist","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib79","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00054725-200501000-00009","article-title":"Primary sclerosing cholangitis","volume":"11","author":"Talwalkar","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.jhep.2008.01.020_bib80","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/hep.20029","article-title":"Prevalence and predictors of esophageal varices in patients with primary sclerosing cholangitis","volume":"39","author":"Zein","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib81","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1080\/00365520410003434","article-title":"Fatigue in patients with primary sclerosing cholangitis","volume":"39","author":"Bjornsson","year":"2004","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib82","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/hep.510270201","article-title":"Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study","volume":"27","author":"Bergquist","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib83","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.1840140209","article-title":"The metabolic bone disease of primary sclerosing cholangitis","volume":"14","author":"Hay","year":"1991","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib84","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib85","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2214\/ajr.157.3.1651643","article-title":"Primary sclerosing cholangitis: a modified classification of cholangiographic findings","volume":"157","author":"Majoie","year":"1991","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2008.01.020_bib86","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s002610000098","article-title":"Evaluation of a modified cholangiographic classification system for primary sclerosing cholangitis","volume":"26","author":"Rajaram","year":"2001","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.jhep.2008.01.020_bib87","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-102-5-581","article-title":"Pericholangitis in chronic ulcerative colitis: primary sclerosing cholangitis of the small bile ducts?","volume":"102","author":"Wee","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib88","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00001574-200405000-00006","article-title":"Cholestatic syndromes","volume":"20","author":"Trauner","year":"2004","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib89","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/gut.52.5.688","article-title":"Progressive sclerosing cholangitis after septic shock: a new variant of vanishing bile duct disorders","volume":"52","author":"Engler","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib90","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1572-0241.2007.01118.x","article-title":"Ischemic-like cholangiopathy with secondary sclerosing cholangitis in critically ill patients","volume":"102","author":"Gelbmann","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib91","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00042737-200304000-00013","article-title":"Idiopathic cholangiopathy in a biliary cast syndrome necessitating liver transplantation following head trauma","volume":"15","author":"Byrne","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib92","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0016-5107(96)70167-0","article-title":"Endoscopic stent therapy for dominant extrahepatic bile duct strictures in primary sclerosing cholangitis","volume":"44","author":"van Milligen de Wit","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib93","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0168-8278(01)00251-3","article-title":"Development of dominant bile duct stenoses in patients with primary sclerosing cholangitis treated with ursodeoxycholic acid: outcome after endoscopic treatment","volume":"36","author":"Stiehl","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib94","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S0016-5107(97)70123-8","article-title":"Lack of complications following short-term stent therapy for extrahepatic bile duct strictures in primary sclerosing cholangitis","volume":"46","author":"van Milligen de Wit","year":"1997","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib95","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJM199609263351301","article-title":"Complications of endoscopic biliary sphincterotomy","volume":"335","author":"Freeman","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib96","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(98)70121-X","article-title":"Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"48","author":"Loperfido","year":"1998","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib97","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1572-0241.2001.03594.x","article-title":"Complications of diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"96","author":"Masci","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib98","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.2214\/ajr.171.4.9762990","article-title":"MR cholangiography in primary sclerosing cholangitis","volume":"171","author":"Ernst","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jhep.2008.01.020_bib99","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.215.1.r00ap2671","article-title":"Primary sclerosing cholangitis: evaluation with MR cholangiography \u2013 a case-control study","volume":"215","author":"Fulcher","year":"2000","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2008.01.020_bib100","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0168-8278(00)80002-1","article-title":"Magnetic resonance cholangiography in patients with biliary disease: its role in primary sclerosing cholangitis","volume":"33","author":"Angulo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib101","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.gie.2005.12.034","article-title":"Diagnosis of primary sclerosing cholangitis: a blinded comparative study using magnetic resonance cholangiography and endoscopic retrograde cholangiography","volume":"64","author":"Moff","year":"2006","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib102","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2005.10.007","article-title":"Diagnostic accuracy of magnetic resonance and endoscopic retrograde cholangiography in primary sclerosing cholangitis","volume":"4","author":"Berstad","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib103","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1055\/s-2002-35830","article-title":"Three-dimensional magnetic resonance cholangiopancreatography with respiratory triggering in the diagnosis of primary sclerosing cholangitis: comparison with endoscopic retrograde cholangiography","volume":"34","author":"Textor","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2008.01.020_bib104","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/jcp.48.10.933","article-title":"Sampling variability of percutaneous liver biopsy in primary sclerosing cholangitis","volume":"48","author":"Olsson","year":"1995","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jhep.2008.01.020_bib105","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1111\/j.1572-0241.2003.07401.x","article-title":"Is there a role for liver biopsy in primary sclerosing cholangitis?","volume":"98","author":"Burak","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib106","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S0025-6196(11)64614-4","article-title":"A revised natural history model for primary sclerosing cholangitis","volume":"75","author":"Kim","year":"2000","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jhep.2008.01.020_bib107","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1111\/j.1572-0241.2000.01999.x","article-title":"Variant forms of cholestatic diseases involving small bile ducts in adults","volume":"95","author":"Kim","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib108","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1136\/gut.51.5.731","article-title":"Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis","volume":"51","author":"Bjornsson","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib109","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S0168-8278(02)00036-3","article-title":"Natural history and outcome in 32 Swedish patients with small duct primary sclerosing cholangitis (PSC)","volume":"36","author":"Broome","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib110","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1053\/jhep.2002.33202","article-title":"Small-duct primary sclerosing cholangitis: a long-term follow-up study","volume":"35","author":"Angulo","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib111","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.21960","article-title":"Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis","volume":"47","author":"Charatcharoenwitthaya","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib112","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","article-title":"International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis","volume":"31","author":"Alvarez","year":"1999","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib113","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1034\/j.1600-0641.2000.033004543.x","article-title":"High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis","volume":"33","author":"van Buuren","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib114","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0168-8278(00)80004-5","article-title":"Overlap of autoimmune hepatitis and primary sclerosing cholangitis: an evaluation of a modified scoring system","volume":"33","author":"Kaya","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib115","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1053\/jhep.2001.22131","article-title":"Autoimmune hepatitis\/sclerosing cholangitis overlap syndrome in childhood: a 16-year prospective study","volume":"33","author":"Gregorio","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib116","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1572-0241.2005.41841.x","article-title":"Clinical course and outcome of autoimmune hepatitis\/primary sclerosing cholangitis overlap syndrome","volume":"100","author":"Floreani","year":"2005","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib117","doi-asserted-by":"crossref","first-page":"S487","DOI":"10.1111\/j.1872-034X.2007.00235.x","article-title":"Sclerosing cholangitis associated with autoimmune pancreatitis","volume":"37","author":"Kawa","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2008.01.020_bib118","doi-asserted-by":"crossref","first-page":"S478","DOI":"10.1111\/j.1872-034X.2007.00243.x","article-title":"Pathology and immunopathology of immunoglobulin G4-related sclerosing cholangitis: the latest addition to the sclerosing cholangitis family","volume":"37","author":"Nakanuma","year":"2007","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jhep.2008.01.020_bib119","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1097\/01.pas.0000136449.37936.6c","article-title":"IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?","volume":"28","author":"Zen","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.jhep.2008.01.020_bib120","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1111\/j.1572-0241.2006.00772.x","article-title":"Elevated serum IgG4 concentration in patients with primary sclerosing cholangitis","volume":"101","author":"Mendes","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib121","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/0016-5085(92)91449-E","article-title":"Primary sclerosing cholangitis: refinement and validation of survival models","volume":"103","author":"Dickson","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib122","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1478-3231.2007.01471.x","article-title":"High aspartate to alanine aminotransferase ratio is an indicator of cirrhosis and poor outcome in patients with primary sclerosing cholangitis","volume":"27","author":"Nyblom","year":"2007","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2008.01.020_bib123","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib124","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/00365520600633495","article-title":"Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis","volume":"41","author":"Tischendorf","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/hep.510310103","article-title":"Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study","volume":"31","author":"Chalasani","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib126","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.jhep.2004.01.002","article-title":"Liver transplantation for primary sclerosing cholangitis; predictors and consequences of hepatobiliary malignancy","volume":"40","author":"Brandsaeter","year":"2004","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib127","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib128","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0168-8278(01)00042-3","article-title":"Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study","volume":"34","author":"Leidenius","year":"2001","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib129","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0016-5085(95)90462-X","article-title":"Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis","volume":"108","author":"Ramage","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib130","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2008.01.020_bib131","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1478-3231.1999.tb00083.x","article-title":"CA 19-9 and CEA are unreliable markers for cholangiocarcinoma in patients with primary sclerosing cholangitis","volume":"19","author":"Bjornsson","year":"1999","journal-title":"Liver"},{"key":"10.1016\/j.jhep.2008.01.020_bib132","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1055\/s-2005-858105","article-title":"Impact of dominant stenoses on the serum level of the tumor marker CA19-9 in patients with primary sclerosing cholangitis","volume":"43","author":"Petersen-Benz","year":"2005","journal-title":"Z Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib133","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jhep.2007.05.017","article-title":"Enhanced detection of cholangiocarcinoma with serum trypsinogen-2 in patients with severe bile duct strictures","volume":"47","author":"Lempinen","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib134","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1148\/radiology.207.1.9530297","article-title":"Biliary tract carcinoma complicating primary sclerosing cholangitis: evaluation with CT, cholangiography, US, and MR imaging","volume":"207","author":"Campbell","year":"1998","journal-title":"Radiology"},{"key":"10.1016\/j.jhep.2008.01.020_bib135","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1002\/hep.21433","article-title":"Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation","volume":"44","author":"Prytz","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib136","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1111\/j.1572-0241.2002.05677.x","article-title":"In primary sclerosing cholangitis, gallbladder polyps are frequently malignant","volume":"97","author":"Buckles","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib137","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1053\/bega.2001.0210","article-title":"Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis","volume":"15","author":"Bergquist","year":"2001","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib138","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jhep.2006.05.010","article-title":"Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis","volume":"45","author":"Boberg","year":"2006","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib139","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1055\/s-1999-18","article-title":"Value of brush cytology for dominant strictures in primary sclerosing cholangitis","volume":"31","author":"Ponsioen","year":"1999","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2008.01.020_bib140","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1055\/s-2002-35298","article-title":"Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis","volume":"34","author":"Lindberg","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2008.01.020_bib141","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0016-5107(95)70012-9","article-title":"Value of endobiliary brush cytology and biopsies for the diagnosis of malignant bile duct stenosis: results of a prospective study","volume":"42","author":"Ponchon","year":"1995","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib142","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1055\/s-2006-925257","article-title":"Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"38","author":"Tischendorf","year":"2006","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2008.01.020_bib143","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.gie.2007.01.025","article-title":"SpyGlass single-operator peroral cholangiopancreatoscopy system for the diagnosis and therapy of bile-duct disorders: a clinical feasibility study (with video)","volume":"65","author":"Chen","year":"2007","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib144","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1080\/00365520701206761","article-title":"Transpapillary intraductal ultrasound in the evaluation of dominant bile duct stenoses in patients with primary sclerosing cholangitis","volume":"42","author":"Tischendorf","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib145","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1136\/gut.48.3.403","article-title":"K-ras mutations in the bile of patients with primary sclerosing cholangitis","volume":"48","author":"Kubicka","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib146","doi-asserted-by":"crossref","first-page":"451","DOI":"10.7326\/0003-4819-147-7-200710020-00003","article-title":"Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis","volume":"147","author":"Alvaro","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib147","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1136\/gut.51.4.562","article-title":"Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population","volume":"51","author":"Ponsioen","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib148","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib149","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365528709011139","article-title":"Primary sclerosing cholangitis: a long-term follow-up study","volume":"22","author":"Aadland","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib150","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1053\/gast.1996.v110.pm8566577","article-title":"Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis","volume":"110","author":"Brentnall","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib151","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/0016-5085(92)90308-L","article-title":"Primary sclerosing cholangitis in ulcerative colitis \u2013 a risk factor for the development of dysplasia and DNA aneuploidy?","volume":"102","author":"Broome","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib152","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/gut.41.4.522","article-title":"Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study","volume":"41","author":"Kornfeld","year":"1997","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib153","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1111\/j.1572-0241.1999.01156.x","article-title":"The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis","volume":"94","author":"Shetty","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib154","first-page":"1404","article-title":"Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential","volume":"22","author":"Broome","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib155","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1053\/gast.2003.50146","article-title":"Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis","volume":"124","author":"Kiesslich","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib156","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1053\/j.gastro.2003.05.021","article-title":"Further validation of high-magnification chromoscopic-colonoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis","volume":"126","author":"Hurlstone","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib157","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.21337","article-title":"Primary sclerosing cholangitis: summary of a workshop","volume":"44","author":"LaRusso","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib158","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib159","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/0016-5085(91)90673-9","article-title":"Natural history and prognostic variables in primary sclerosing cholangitis","volume":"100","author":"Farrant","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib160","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1053\/gast.2001.27965","article-title":"A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis","volume":"121","author":"Mitchell","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib161","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/j.1572-0241.2001.03777.x","article-title":"High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis","volume":"96","author":"Harnois","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib162","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/hep.20370","article-title":"Effect of high-dose ursodeoxycholic acid on its biliary enrichment in primary sclerosing cholangitis","volume":"40","author":"Rost","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib163","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1053\/j.gastro.2005.08.017","article-title":"High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study","volume":"129","author":"Olsson","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib164","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2003.50156","article-title":"Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"124","author":"Pardi","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib165","doi-asserted-by":"crossref","first-page":"89","DOI":"10.7326\/0003-4819-134-2-200101160-00008","article-title":"Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis","volume":"134","author":"Tung","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jhep.2008.01.020_bib166","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/S0002-9270(00)01059-5","article-title":"Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group","volume":"95","author":"van Hoogstraten","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib167","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/hep.510230612","article-title":"Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis","volume":"23","author":"Boberg","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib168","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/s-2005-916322","article-title":"Overlap syndromes","volume":"25","author":"Beuers","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2008.01.020_bib169","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1055\/s-2006-933564","article-title":"Primary sclerosing cholangitis: the role of endoscopic therapy","volume":"26","author":"Stiehl","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2008.01.020_bib170","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1385\/CRIAI:28:2:159","article-title":"Endoscopic treatment of dominant stenoses in patients with primary sclerosing cholangitis","volume":"28","author":"Stiehl","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jhep.2008.01.020_bib171","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/j.1572-0241.2004.04106.x","article-title":"Dominant strictures in patients with primary sclerosing cholangitis","volume":"99","author":"Bjornsson","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib172","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5107(91)70618-4","article-title":"Endoscopic treatment of biliary tract strictures in sclerosing cholangitis: a larger series and recommendations for treatment","volume":"37","author":"Johnson","year":"1991","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib173","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1136\/gut.32.11.1364","article-title":"Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods","volume":"32","author":"Lombard","year":"1991","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2008.01.020_bib174","first-page":"387","article-title":"Endoscopic therapy in primary sclerosing cholangitis: outcome of treatment and risk of cancer","volume":"48","author":"Linder","year":"2001","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0016-5107(01)70403-8","article-title":"Impact of endoscopic therapy on the survival of patients with primary sclerosing cholangitis","volume":"53","author":"Baluyut","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.jhep.2008.01.020_bib176","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1055\/s-2007-1005552","article-title":"Endoscopic management of biliary tract strictures in primary sclerosing cholangitis","volume":"28","author":"Wagner","year":"1996","journal-title":"Endoscopy"},{"key":"10.1016\/j.jhep.2008.01.020_bib177","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S0168-8278(86)80155-6","article-title":"Biliary lavage with corticosteroids in primary sclerosing cholangitis. A clinical, cholangiographic and bacteriological study","volume":"3","author":"Allison","year":"1986","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2008.01.020_bib178","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1572-0241.2006.00383.x","article-title":"Is there a role for cholangioscopy in patients with primary sclerosing cholangitis?","volume":"101","author":"Awadallah","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2008.01.020_bib179","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/hep.1840160527","article-title":"Selection and timing of liver transplantation in primary biliary cirrhosis and primary sclerosing cholangitis","volume":"16","author":"Wiesner","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.sla.0000179678.13285.fa","article-title":"Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma","volume":"242","author":"Rea","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.jhep.2008.01.020_bib181","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1034\/j.1600-6143.2002.20812.x","article-title":"Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma","volume":"2","author":"Sudan","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jhep.2008.01.020_bib182","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.510300501","article-title":"Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis","volume":"30","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib183","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/hep.510290427","article-title":"Recurrence of primary sclerosing cholangitis following liver transplantation","volume":"29","author":"Graziadei","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2008.01.020_bib184","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1007\/s11605-007-0282-0","article-title":"Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysis","volume":"11","author":"Nathan","year":"2007","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.jhep.2008.01.020_bib185","first-page":"23","article-title":"Radical surgery for hilar cholangiocarcinoma","author":"Jonas","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.jhep.2008.01.020_bib186","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/lt.21107","article-title":"Vascular complications after orthotopic liver transplantation after neoadjuvant therapy for hilar cholangiocarcinoma","volume":"13","author":"Mantel","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhep.2008.01.020_bib187","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.gastro.2003.07.015","article-title":"Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study","volume":"125","author":"Ortner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2008.01.020_bib188","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1158\/1535-7163.MCT-05-0425","article-title":"Low doses of cisplatin or gemcitabine plus photofrin\/photodynamic therapy: disjointed cell cycle phase-related activity accounts for synergistic outcome in metastatic non-small cell lung cancer cells (H1299)","volume":"5","author":"Crescenzi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jhep.2008.01.020_bib189","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00108-006-1774-9","article-title":"Systemic treatment of liver and biliary tumors","volume":"48","author":"Malek","year":"2007","journal-title":"Internist (Berl)"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827808000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827808000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T05:12:52Z","timestamp":1630732372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827808000597"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":189,"alternative-id":["S0168827808000597"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2008.01.020","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2008]]}}}